Company Filing History:
2 out of 3,923 
2 out of 84 Years Active: 2013-2015
Title: Judy Abraham: A Patent Innovator in Cancer Research
Introduction:
In the field of inventions and patents, one individual stands out for their contributions to the advancement of cancer research: Judy Abraham. With a passion for developing solutions to combat this devastating disease, Judy has garnered recognition for her inventive mind and dedication to finding novel treatments. Let's take a closer look at Judy's background, patents, and collaborations within the pharmaceutical industry.
Background and Location:
Judy Abraham is based in San Jose, California, making her mark on the innovative landscape in the heart of technological advancements. Located in close proximity to Silicon Valley, this thriving region provides the perfect environment for individuals like Judy to channel their creative energies and collaborate with like-minded professionals.
Patents:
Judy Abraham has an impressive portfolio of two patents, with a particular focus on developing EPHB3-specific antibodies. Her latest patents, titled "EPHB3-specific antibody and uses thereof," highlight her dedication to finding new methods of preventing and treating cancer. These inventions include the antibodies themselves, pharmaceutical compositions containing the antibodies, and related kits. This breakthrough holds promise for advancing cancer therapies and improving patient outcomes.
Companies and Collaborations:
Throughout her career, Judy Abraham has had the opportunity to work with renowned companies in the pharmaceutical industry. She has contributed her expertise to Novartis AG, a globally recognized company at the forefront of innovative healthcare solutions. Additionally, Judy has collaborated with XOMA TECHNOLOGY LTD. (formerly XOMA Corporation), an organization known for its pioneering work in developing antibody-based therapeutics.
Collaborators:
Judy Abraham has had the privilege to collaborate with esteemed colleagues in her endeavors. Notable among them are Jeff Hsu and Linda Masat, whose contributions have undoubtedly enriched the outcomes of their joint projects. Together, these remarkable individuals have shared their expertise and combined efforts to advance cancer research and treatment methods.
Conclusion:
Judy Abraham's dedication to cancer research and her contributions to the development of EPHB3-specific antibodies exemplify her innovation and commitment to combating this devastating disease. Through her work with prestigious companies and collaborations, Judy has made a significant impact on the field of cancer therapeutics. As her patents continue to inspire and influence further advancements, we anticipate more breakthroughs from this brilliant inventor in the future.
For more information on innovators, patents, and inventions, visit our website at iDIYAS.com, where we celebrate the brilliance of minds like Judy Abraham.